Orbactiv
Active substance: oritavancin
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ORITAVANCIN 400 mg/1
United StatesActive
Marketing holder: Melinta Therapeutics, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- ORITAVANCIN · 400 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 1 |
|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12090-bcce-72ad-a102-34c9deb924df;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70842-140
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 70842-140 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70842-140 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70842-140 · Verified 2026-10-09 · open in source